Health claims here range from coffee and post-meal walking benefits to estrogen metabolism, AI imaging in cancer care, and disputed COVID-19 origin narratives.
530 Health claim verifications avg. score 5.1/10 209 rated true or mostly true 254 rated false or mostly false
“Excessive dietary salt intake lowers estrogen levels in women.”
The evidence does not support the claim that excessive dietary salt intake lowers estrogen levels in women. The only direct human study cited found that changing sodium intake did not alter estrone or estradiol in postmenopausal women. Studies in this evidence set mainly show the opposite relationship: estrogen influences salt sensitivity and fluid balance, while animal findings suggesting hormonal changes with high salt do not establish the same effect in women.
“Smoking in women can cause aromatase deficiency.”
The evidence does not support the claim as stated. Smoking and nicotine can inhibit aromatase activity and lower estrogen in women, but that is not the same as causing aromatase deficiency, which is a rare genetic disorder caused by CYP19A1 mutations. The claim conflates temporary enzyme inhibition with a distinct inherited medical condition.
“Processed meat is classified in the same International Agency for Research on Cancer (IARC) carcinogenicity category as tobacco smoking (cigarettes).”
IARC and WHO sources explicitly place processed meat consumption and tobacco smoking in the same IARC Group 1 category, meaning there is sufficient evidence they can cause cancer in humans. The claim is accurate as stated. The main caveat is that sharing a category does not mean they pose the same level of risk.
“Obesity in women causes excessive levels of dihydrotestosterone (DHT).”
The evidence does not show that obesity in women causes excessive DHT levels. Studies commonly find that obese women may have higher DHT production or altered adipose androgen metabolism, but faster clearance offsets this, leaving circulating DHT similar or even lower than in lean women. The claim also blurs local tissue findings with whole-body hormone levels.
“Male obesity causes excess estriol levels in men.”
The claim is not supported by the evidence. Research on obesity in men consistently shows increased conversion of androgens into estradiol, and sometimes estrone, in adipose tissue; it does not show that obesity causes excess estriol. Because estriol is a distinct estrogen and the cited studies do not document elevated estriol in obese men, the claim is false as written.
“Being underweight in men causes a deficiency of dihydrotestosterone (DHT).”
Available evidence does not show that being underweight in men causes DHT deficiency. Research more commonly associates lower DHT with higher body fat or obesity, while underweight-related studies focus on hypogonadism or testosterone and do not directly demonstrate low DHT. The claim makes a specific causal statement that the cited evidence does not substantiate.
“Insulin therapy causes weight gain in people with diabetes.”
Clinical evidence consistently identifies insulin therapy as a common cause of weight gain in diabetes. Major guidelines and reviews describe several mechanisms, including reduced calorie loss in urine, anabolic effects, and compensatory eating to avoid hypoglycemia. The effect is not inevitable, and its size varies by regimen and lifestyle, but those caveats do not change the main conclusion.
“In ducks with egg binding, inability to lay an egg and inability to pass feces can occur simultaneously and the duck’s condition can rapidly worsen.”
The evidence supports this as an emergency pattern seen in egg-bound ducks. Veterinary references indicate a retained egg can prevent laying and also reduce or stop fecal passage, and they warn that affected birds may deteriorate rapidly without treatment. The exact timeline and severity vary, but the core claim is well supported.
“Copper surfaces kill bacteria through contact (without additional disinfectants).”
The evidence strongly supports that copper surfaces can kill bacteria through intrinsic contact-mediated antimicrobial action, without needing added disinfectants. EPA registrations and multiple mechanistic studies show the effect is built into the copper surface itself. The main caveat is that performance depends on conditions such as cleanliness, alloy type, and sufficient contact time.
“The amount of sleep loss caused by high temperatures that is attributable to climate change has at least doubled since the early 1970s.”
Available evidence supports the claim: modeled climate-attributable heat-related sleep loss rose from roughly 2 hours per person per year in the early 1970s to about 5 hours in 2020-2025, which is more than a doubling. The main caveat is that this exact doubling estimate comes primarily from one attribution analysis rather than multiple independent replications.
“Some people who are classified as overweight can be metabolically healthy.”
The evidence shows that a subset of people in the overweight BMI range meet standard clinical criteria for metabolic health. Multiple reviews and cohort studies explicitly recognize this phenotype. Ongoing debate about whether these individuals still face higher long-term cardiovascular risk does not negate the narrower claim that they can be metabolically healthy at a given time.
“Body-mass index (BMI) can misclassify fit, muscular people as overweight or obese because muscle is denser than fat.”
The claim matches the medical literature. BMI relies on height and weight alone, so people with unusually high muscle mass can be placed in overweight or obese BMI ranges even when their body fat is low. The “muscle is denser than fat” explanation is a valid shorthand for why this happens, though BMI category alone is not a full diagnosis of obesity.
“In women, lower estrogen levels are associated with increased fingernail hardness.”
Available evidence does not support this association. Sources consistently describe lower estrogen as contributing to reduced nail hydration and keratin support, leading to brittle, weaker, thinner, softer, and more breakable nails rather than harder ones. The claim relies on conflating fragility or rigidity from dryness with true hardness.
“Low testosterone levels can cause obesity in men.”
Low testosterone can contribute to fat gain and, in some men, to obesity. Mechanistic, longitudinal, and clinical evidence indicates that testosterone deficiency promotes adiposity and visceral fat accumulation, especially in more severe hypogonadal states. However, the relationship is bidirectional, and obesity is more often a cause of low testosterone than the primary result of it.
“Low testosterone levels can be a cause of underweight in people of any sex.”
The evidence does not support low testosterone as a cause of underweight. Across the cited medical literature, low testosterone is associated mainly with increased adiposity, reduced lean mass, and weight gain or impaired weight loss, not low body weight. The claim also confuses loss of muscle with being underweight and overgeneralizes across sexes without support.
“A deficiency of estrogen (female sex hormones) can be a cause of underweight in people of any sex.”
The evidence does not support estrogen deficiency as a cause of underweight. In the stronger medical literature, low estrogen is more often linked to increased fat mass and weight gain, while underweight and calorie deficiency commonly cause low estrogen by suppressing reproductive hormone function. The claim reverses the usual direction of causation and overgeneralizes across sexes.
“Women with excessive muscle mass have reduced estrogen levels.”
The evidence does not support a general rule that muscular women have reduced estrogen levels. Most higher-quality research indicates estrogen helps preserve and build muscle in women, while low estrogen is more often linked to muscle loss or menopause-related decline. Cases where very lean or elite female athletes have low estrogen are usually explained by low energy availability, menstrual dysfunction, or other confounders rather than muscle mass itself.
“Excessive muscle mass in men causes estrogen deficiency.”
The evidence does not support the idea that excessive muscle mass in men causes estrogen deficiency. In men, low estrogen is usually linked to low testosterone, impaired aromatization, certain drugs, or endocrine disease—not to having a lot of muscle. Several credible sources point in the opposite direction or find no such causal relationship.
“In men, having low muscle mass causes estrogen levels to become abnormally high.”
The evidence does not support low muscle mass as a cause of abnormally high estrogen in men. Higher estradiol is more consistently associated with increased fat mass and aromatization, while studies often find weak, inconsistent, or no independent link between estradiol and muscle mass. The claim confuses low muscle with high body fat and overstates both causation and hormone abnormality.
“A cure for multiple sclerosis has been discovered.”
Current evidence does not support the statement that a cure for multiple sclerosis has been discovered. Authoritative medical sources explicitly say there is no cure for MS, while newer therapies only reduce relapses, slow progression, or show early repair potential. Promising trial results are not the same as a proven cure.